Literature DB >> 2305584

Pyogenic liver abscess.

E D Bowers1, D J Robison, R C Doberneck.   

Abstract

Experience with 34 patients with pyogenic liver abscess is reviewed to evaluate the impact of percutaneous drainage and duration of antibiotic therapy on results of treatment. Patients with shock, adult respiratory distress syndrome, disseminated intravascular coagulation, jaundice, severe hypoalbuminemia, and diabetes had a poor prognosis. Percutaneous drainage was used successfully in 4 of 6 patients, but its use did not affect mortality rate or length of hospital stay. Percutaneous drainage may be the procedure of choice for selected patients. Half of our patients received antibiotics for 2 weeks or less with no abscess recurrences in this group. Long-term antibiotics may not be necessary after adequate surgical or percutaneous abscess drainage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305584     DOI: 10.1007/bf01670563

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  Solitary pyogenic abscess of the liver treated by closed aspiration and antibiotics; a report of 14 consecutive cases with recovery.

Authors:  A J McFADZEAN; K P CHANG; C C WONG
Journal:  Br J Surg       Date:  1953-09       Impact factor: 6.939

2.  Successful medical treatment of pyogenic liver abscess.

Authors:  J A Maher; T B Reynolds; A E Yellin
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

3.  Treatment of liver abscesses. A conservative surgical approach.

Authors:  E M Tetz; C D Reeves; J K Longerbeam
Journal:  Am J Surg       Date:  1973-08       Impact factor: 2.565

4.  Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects.

Authors:  R H Rubin; M N Swartz; R Malt
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

5.  Liver abscess as a complication of regional enteritis: interventional considerations.

Authors:  J R Crass
Journal:  Am J Gastroenterol       Date:  1983-11       Impact factor: 10.864

6.  Pyogenic liver abscess.

Authors:  J P Neoptolemos; D S Macpherson
Journal:  Br J Hosp Med       Date:  1981-07

7.  Percutaneous catheter drainage of abdominal abscesses: a five-year experience.

Authors:  S G Gerzof; A H Robbins; W C Johnson; D H Birkett; D C Nabseth
Journal:  N Engl J Med       Date:  1981-09-17       Impact factor: 91.245

8.  Factors influencing mortality in the treatment of pyogenic hepatic abscess.

Authors:  H A Pitt; G D Zuidema
Journal:  Surg Gynecol Obstet       Date:  1975-02

9.  Unsuspected hepatic abscess associated with biliary tract disease.

Authors:  M G Fischer; H L Beaton
Journal:  Am J Surg       Date:  1983-11       Impact factor: 2.565

10.  Drainage of hepatic, intraabdominal, and mediastinal abscesses guided by computerized axial tomography. Successful alternative to open drainage.

Authors:  S R Mandel; D Boyd; P F Jaques; V Mandell; E V Staab
Journal:  Am J Surg       Date:  1983-01       Impact factor: 2.565

View more
  4 in total

1.  Pyogenic liver abscess: an audit of 10 years' experience.

Authors:  Tony C Y Pang; Thomas Fung; Jaswinder Samra; Thomas J Hugh; Ross C Smith
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

2.  Pyogenic liver abscesses: a comparison of older and younger patients.

Authors:  J A Alvarez; J J González; R F Baldonedo; L Sanz; A Junco; J L Rodrfíguez; M D Martínez
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

3.  Predictive factors for early aspiration in liver abscess.

Authors:  Rustam Khan; Saeed Hamid; Shahab Abid; Wasim Jafri; Zaigham Abbas; Mohammed Islam; Hasnain Shah; Shaalan Beg
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

4.  Clinical Charateristics and Outcome of Pyogenic Liver Abscess with Different Size: 15-Year Experience from a Single Center.

Authors:  Zhao-Qing Du; Li-Na Zhang; Qiang Lu; Yi-Fan Ren; Yi Lv; Xue-Min Liu; Xu-Feng Zhang
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.